These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 11282268)
41. [A study of prostatic tissue levels of cefbuperazone]. Izumi H; Ikeda S; Ishibashi A; Koshiba K Hinyokika Kiyo; 1987 Aug; 33(8):1316-8. PubMed ID: 2447766 [TBL] [Abstract][Full Text] [Related]
42. [Clinical and laboratory investigation of pefloxacin used prophylactically in operations on the liver]. Khlebnikov EP; Vishnevskiĭ VA; Kubyshkin VA; Terekhova RP Antibiot Khimioter; 2009; 54(3-4):32-7. PubMed ID: 19711848 [No Abstract] [Full Text] [Related]
43. Intravitreal penetration of oral pefloxacin in humans. Oncel M; Peyman GA Int Ophthalmol; 1993 Aug; 17(4):217-22. PubMed ID: 8112969 [TBL] [Abstract][Full Text] [Related]
44. Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral dose. Hofbauer H; Naber KG; Kinzig-Schippers M; Sörgel F; Rustige-Wiedemann C; Wiedemann B; Reiz A; Kresken M Infection; 1997; 25(2):121-6. PubMed ID: 9108190 [TBL] [Abstract][Full Text] [Related]
45. [A study of prostatic tissue levels of latamoxef, cefoperazone and cefotaxime]. Takeuchi N; Kinukawa T; Matsuura O; Hattori R; Hasegawa S; Ohshima S; Ono Y Hinyokika Kiyo; 1986 Dec; 32(12):1831-41. PubMed ID: 2435132 [TBL] [Abstract][Full Text] [Related]
46. Evaluation of the efficacy of sequential intravenous-oral administration of pefloxacin in community-acquired lower respiratory tract infections in patients with underlying conditions. Yap JC; Wang YT; Chan CC; Ng A; Poh SC Singapore Med J; 1995 Oct; 36(5):484-6. PubMed ID: 8882529 [TBL] [Abstract][Full Text] [Related]
47. [Pharmacokinetic basis for the use of pefloxacin in severe forms of infectious-inflammatory diseases]. Navashin PS; Smirnova LB Antibiot Khimioter; 1998; 43(12):30-8. PubMed ID: 10079873 [No Abstract] [Full Text] [Related]
49. Pharmacokinetics and tissue residues of pefloxacin and its metabolite norfloxacin in broiler chickens. Pant S; Rao GS; Sastry KV; Tripathi HC; Jagmohan ; Malik JK Br Poult Sci; 2005 Oct; 46(5):615-20. PubMed ID: 16359117 [TBL] [Abstract][Full Text] [Related]
50. Tissue concentrations of mezlocillin in benign hypertrophy of the prostate following intravenous bolus injection versus infusion. Naber KG; Adam D J Antimicrob Chemother; 1983 May; 11 Suppl C():17-23. PubMed ID: 6194144 [TBL] [Abstract][Full Text] [Related]
51. Pharmacokinetics and bactericidal activities of one 800-milligram dose versus two 400-milligram doses of intravenously administered pefloxacin in healthy volunteers. Petitjean O; Pangon B; Brion N; Tod M; Chaplain C; Le Gros V; Louchahi K; Allouch P Antimicrob Agents Chemother; 1993 Apr; 37(4):737-40. PubMed ID: 8494368 [TBL] [Abstract][Full Text] [Related]
52. Concentration-time courses of pefloxacin in plasma and milk of lactating she-camels (Camelus dromedarius). Goudah A; Shah SS; Shin HC; Chang BJ; Shim JH; Abd El-Aty AM Berl Munch Tierarztl Wochenschr; 2008; 121(11-12):432-9. PubMed ID: 19086693 [TBL] [Abstract][Full Text] [Related]
53. [Prostaglandin E2 in prostatitis and prostatic adenoma]. Bauer HW; Bach D Urol Int; 1986; 41(2):139-44. PubMed ID: 2425472 [TBL] [Abstract][Full Text] [Related]
55. [Tissue concentrations of sulfametrol-trimethoprim in the human prostate (author's transl)]. Bergmann M; Lederer B; Takacs F Urologe A; 1979 Nov; 18(6):335-7. PubMed ID: 92090 [TBL] [Abstract][Full Text] [Related]
56. Comparison of ofloxacin and norfloxacin concentration in prostatic tissues in patients undergoing transurethral resection of the prostate. Chen J; Chen RR; Huang HS J Formos Med Assoc; 2001 Aug; 100(8):548-52. PubMed ID: 11678006 [TBL] [Abstract][Full Text] [Related]
57. [Infection prophylaxis in open leg fractures. Comparison of a dose of pefloxacin and 5 days of cefazolin-oxacillin. A randomized study of 616 cases]. Gagey O; Doyon F; Dellamonica P; Carsenti-Etesse H; Desplaces N; Tancrède C; Evrard J Rev Chir Orthop Reparatrice Appar Mot; 1999 Jul; 85(4):328-36. PubMed ID: 10457551 [TBL] [Abstract][Full Text] [Related]
58. Pharmacokinetics of fluoroquinolones in uncompensated cirrhosis: the significance of penetration in the ascitic fluid. Sambatakou H; Giamarellos-Bourboulis EJ; Galanakis N; Giamarellou H Int J Antimicrob Agents; 2001 Nov; 18(5):441-4. PubMed ID: 11711259 [TBL] [Abstract][Full Text] [Related]
59. Comparative efficacies of oral pefloxacin in uncomplicated cystitis. Single dose or 3-day therapy. Leelarasamee A; Leelarasamee I Drugs; 1995; 49 Suppl 2():365-7. PubMed ID: 8549364 [No Abstract] [Full Text] [Related]
60. One-dose treatment with pefloxacin for infection due to multidrug-resistant Shigella dysenteriae type 1 in Burundi. Gendrel D; Moreno JL; Nduwimana M; Baribwira C; Raymond J Clin Infect Dis; 1997 Jan; 24(1):83. PubMed ID: 8994771 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]